| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |